Project:Clinical practice working group

Coordinating dosing, administration, handling and adverse-effect articles.

The clinical practice working group covers what happens between a vial and a measurement: preparation and handling, administration, titration, monitoring, and the adverse effects that follow. It shares the adverse-effect articles with the clinical evidence group and the handling articles with the analytical group.

Reconstitution, diluents and beyond-use dating; injection technique and devices; dose escalation and missed doses; adverse effects and their management; laboratory monitoring and body composition. Compound-specific pharmacology belongs to the pharmacology group.

This group's articles are the ones most likely to drift from description into instruction, because the subjects are procedures. The rule the group works to is mechanism first, consequence second: explain why directing diluent down the vial wall reduces interfacial stress, and let the reader draw the practical conclusion. An article that states a practice without its mechanism has become guidance and needs rewriting.

Nothing in this group's scope is medical advice, and every article carrying handling material states so.

1. Audit every handling article for sentences that instruct rather than explain.
2. Ensure any table of doses, volumes or analytes is immediately followed by a statement of what it is not.
3. Source the injection-site rotation material to studies in the relevant dosing frequency rather than to basal-bolus insulin work.
4. Reconcile the storage and beyond-use material, which is currently spread across four articles saying overlapping things.